Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-12-01T02:29:02.254Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of cessation of creatine supplementation on endogenous creatine synthesis

Published online by Cambridge University Press:  12 May 2008

X. Li ,
M. Xiang ,
L. S. Harbige  and
H. Ai
X. Li
Affiliation:
Division of Nutrition and Biochemistry, Institute of Sports Medicine, The Third Hospital, Peking University, Beijing, People's Republic of China
M. Xiang
Affiliation:
Centre for Biosciences Research, School of Science, University of Greenwich, Kent ME4 4TB, UK
L. S. Harbige
Affiliation:
Centre for Biosciences Research, School of Science, University of Greenwich, Kent ME4 4TB, UK Medway School of Pharmacy, University of Kent and University of Greenwich, Kent ME4 4TB, UK
H. Ai
Affiliation:
Division of Nutrition and Biochemistry, Institute of Sports Medicine, The Third Hospital, Peking University, Beijing, People's Republic of China
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
1st International Immunonutrition Workshop, Valencia, 3–5 October 2007, Valencia, Spain
Information
Proceedings of the Nutrition Society , Volume 67 , Issue OCE1: 1st International Immunonutrition Workshop, Valencia, 3–5 October 2007, Valencia, Spain , May 2008 , E49
Copyright
Copyright © The Authors 2008

Creatine (Cre) can be obtained exogenously from either the diet or supplementation(Reference Pan and Takahashi1–Reference Silva, Machado Reis, Guidetti, Bessone Alves, Mota, Freitas and Baldari3). It can also be endogenously synthesised in man and other mammals(Reference Derave, Marescau, Vanden Eede, Eijnde, De Deyn and Hespel4, Reference Braissant, Henry, Loup, Eilers and Bachmann5). One of the adverse effects of Cre supplementation is that l-arginine:glycine amidinotransferase (L-AGAT), a key enzyme in the endogenous Cre synthesis in mammals, may be severely inhibited(Reference Wyss and Kaddurah-Daouk6). The present study investigated the time-course of recovery of L-AGAT activity and guanidinoacetic acid (GAA) concentration after 1 week of supplementation with 3.0 g Cre/kg body weight per d Cre in adult male Sprague-Dawley rats. On days 1, 2, 4, 8, 16 and 32 (ten treatment and ten control rats per time point) after the 7 d supplementation period L-AGAT activity and GAA concentration in the kidney recovered (%) by 32.8, 51.5, 76.1, 94.4, 100.2 and 102.0 (Figure (A)) and 77.9, 86.2, 96.8, 100.6, 101.1 and 108.0 (Figure (B)) respectively when compared with their respective controls. The total Cre in the gastrocnemius muscle decreased rapidly and reached its lowest level on day 4 after the supplementation period, and then increased gradually. No significant differences were found in serum Cre kinase activity and serum creatinine in the experimental groups when compared with their respective control groups.

These findings indicate that in rats the reduction in L-AGAT activity and GAA concentration associated with supplementation with 3.0 g Cre/kg per d for 1 week could be reversed, suggesting that short-term and high-dose Cre supplementation does not result in depression of endogenous Cre metabolism. As little is known about the effect of Cre supplementation on the immune system, investigation of the effect of long-term and high-dose Cre supplementation on endogenous Cre metabolism in the immune cells of rats will be of interest.

References

1. Pan, JW & Takahashi, K (2007) Am J Physiol 292, R1745–R1750.Google Scholar
2. Candow, DG & Chilibeck, PD (2007) J Nutr Health Aging 11, 185–188.Google Scholar
3. Silva, AJ, Machado Reis, V, Guidetti, L, Bessone Alves, F, Mota, P, Freitas, J & Baldari, C (2007) J Sports Med Phys Fitness 47, 58–64.Google Scholar
4. Derave, W, Marescau, B, Vanden Eede, E, Eijnde, BO, De Deyn, PP & Hespel, P (2004) J Appl Physiol 97, 852–857.CrossRefGoogle Scholar
5. Braissant, O, Henry, H, Loup, M, Eilers, B & Bachmann, C (2001) Brain Res Mol Brain Res 86, 193–201.CrossRefGoogle Scholar
6. Wyss, M & Kaddurah-Daouk, R (2000) Physiol Rev 80, 1107–1213.CrossRefGoogle Scholar